4CSY - JenaLib

Asymmetric Unit (Jmol Viewer)

Asym. Unit - sites (Jmol Viewer)

Biological Unit 1 (Jmol Viewer)

Biol. Unit 1 - sites (Jmol Viewer)

Biological Unit 2 (Jmol Viewer)

Title :   E-SELECTIN LECTIN, EGF-LIKE AND TWO SCR DOMAINS COMPLEXED WITH SIALYL LEWIS X

Authors :   R. C. Preston, R. P. Jakob, F. P. C. Binder, C. P. Sager, B. Ernst, T. Maier

Date :   11 Mar 14 (Deposition) - 24 Sep 14 (Release) - 27 Jan 16 (Revision)

Method :   X-RAY DIFFRACTION

Resolution :   2.41

Chains :   Asym. Unit : A,B
Biol. Unit 1: A  (1x)
Biol. Unit 2: B  (1x)

Keywords :   Cell-Adhesion, Human Lectin, C-Type Lectin, Inflammation, Leukocyte, Sialyl Lewis X, Slex, Protein Conformation, Ligand-Induced Conformational Change, Catch- Bond (Keyword Search: [Gene Ontology, PubMed, Web (Google)] )

Reference :   R. C. Preston, R. P. Jakob, F. P. Binder, C. P. Sager, B. Ernst, T. Maier
E-Selectin Ligand Complexes Adopt An Extended High-Affinity Conformation.
J. Mol. Cell. Biol. V. 8 62 2016
PubMed-ID: 26117840 | Reference-DOI: 10.1093/JMCB/MJV046

Molecule 1 - E-SELECTIN
	Chains	:	A, B
	Engineered	:	YES
	Expression System	:	CRICETULUS GRISEUS
	Expression System Cell Line	:	CHINESE HAMSTER OVARY (CHO) CELLS
	Expression System Common	:	CHINESE HAMSTER
	Expression System Plasmid	:	PCDNA3.1
	Expression System Taxid	:	10029
	Expression System Tissue	:	OVARY
	Expression System Vector Type	:	PLASMID
	Fragment	:	LECTIN DOMAIN, EGF-LIKE DOMAIN, SHORT CONSENSUS REPEAT DOMAIN 1, SHORT CONSENSUS REPEAT DOMAIN 2, RESIDUES 22-301
	Organism Common	:	HUMAN
	Organism Scientific	:	HOMO SAPIENS
	Organism Taxid	:	9606
	Other Details	:	N-ACETYLGLUCOSAMINE RESIDUES ATTACHED TO ASN4, ASN124, ASN139, ASN158, ASN178, ASN182, AND ASN244 ON BOTH CHAINS.
	Synonym	:	CD62 ANTIGEN-LIKE FAMILY MEMBER E, ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1, ELAM-1, LEUKOCYTE-ENDOTHELIAL CELL ADHESION MOLECULE 2, LECAM2
	Tissue	:	CYTOKINE-INDUCED VASCULAR ENDOTHELIAL CELLS

		1	2
Asymmetric Unit	:	A	B
Biological Unit 1 (1x)	:	A
Biological Unit 2 (1x)	:		B

Summary Information (see also Sequences/Alignments below)

Asymmetric Unit (6, 24)

No.	Name	Count	Type	Full Name
1	CA	2	Ligand/Ion	CALCIUM ION
2	FUC	2	Ligand/Ion	ALPHA-L-FUCOSE
3	GAL	2	Ligand/Ion	BETA-D-GALACTOSE
4	MAG	2	Ligand/Ion	BETA-METHYL-N-ACETYL-D-GLUCOSAMINE
5	NAG	14	Ligand/Ion	N-ACETYL-D-GLUCOSAMINE
6	SIA	2	Ligand/Ion	O-SIALIC ACID

Biological Unit 1 (5, 11)

No.	Name	Count	Type	Full Name
1	CA	-1	Ligand/Ion	CALCIUM ION
2	FUC	1	Ligand/Ion	ALPHA-L-FUCOSE
3	GAL	1	Ligand/Ion	BETA-D-GALACTOSE
4	MAG	1	Ligand/Ion	BETA-METHYL-N-ACETYL-D-GLUCOSAMINE
5	NAG	7	Ligand/Ion	N-ACETYL-D-GLUCOSAMINE
6	SIA	1	Ligand/Ion	O-SIALIC ACID

Biological Unit 2 (5, 11)

No.	Name	Count	Type	Full Name
1	CA	-1	Ligand/Ion	CALCIUM ION
2	FUC	1	Ligand/Ion	ALPHA-L-FUCOSE
3	GAL	1	Ligand/Ion	BETA-D-GALACTOSE
4	MAG	1	Ligand/Ion	BETA-METHYL-N-ACETYL-D-GLUCOSAMINE
5	NAG	7	Ligand/Ion	N-ACETYL-D-GLUCOSAMINE
6	SIA	1	Ligand/Ion	O-SIALIC ACID

Asymmetric Unit (18, 18)

No.	Name	Evidence	Residues	Description
01	AC1	SOFTWARE	GLU A:80 , ASN A:82 , GLU A:88 , ASN A:105 , ASP A:106 , FUC A:304	BINDING SITE FOR RESIDUE CA A 306
02	AC2	SOFTWARE	GLU B:80 , ASN B:82 , GLU B:88 , ASN B:105 , ASP B:106 , FUC B:304	BINDING SITE FOR RESIDUE CA B 306
03	AC3	SOFTWARE	ASN A:4 , ARG A:22 , GLU A:208 , LEU B:151 , NAG B:282	BINDING SITE FOR MONO-SACCHARIDE NAG A 285 BOUND TO ASN A 4
04	AC4	SOFTWARE	ASN A:124 , GLU B:71 , LYS B:74	BINDING SITE FOR MONO-SACCHARIDE NAG A 286 BOUND TO ASN A 124
05	AC5	SOFTWARE	ASN A:139 , TYR A:140 , NAG B:285	BINDING SITE FOR MONO-SACCHARIDE NAG A 282 BOUND TO ASN A 139
06	AC6	SOFTWARE	SER A:149 , GLN A:155 , ILE A:156 , ASN A:158 , PRO A:238 , NAG A:284 , HOH A:2037 , HOH A:2056 , ASN B:158 , NAG B:283	BINDING SITE FOR MONO-SACCHARIDE NAG A 283 BOUND TO ASN A 158
07	AC7	SOFTWARE	ASN A:178 , VAL A:224 , THR A:225 , VAL A:232 , CYS A:234 , PHE A:241 , NAG A:283 , HOH A:2048 , GLU B:233 , NAG B:284	BINDING SITE FOR MONO-SACCHARIDE NAG A 284 BOUND TO ASN A 178
08	AC8	SOFTWARE	ASN A:182	BINDING SITE FOR MONO-SACCHARIDE NAG A 281 BOUND TO ASN A 182
09	AC9	SOFTWARE	TYR A:193 , TRP A:243 , ASN A:244	BINDING SITE FOR MONO-SACCHARIDE NAG A 287 BOUND TO ASN A 244
10	BC1	SOFTWARE	LEU A:151 , NAG A:282 , ASN B:4 , ARG B:22 , HOH B:2001	BINDING SITE FOR MONO-SACCHARIDE NAG B 285 BOUND TO ASN B 4
11	BC2	SOFTWARE	GLU A:71 , LYS A:74 , ASN B:124 , HOH B:2021	BINDING SITE FOR MONO-SACCHARIDE NAG B 286 BOUND TO ASN B 124
12	BC3	SOFTWARE	NAG A:285 , ASN B:139 , TYR B:140	BINDING SITE FOR MONO-SACCHARIDE NAG B 282 BOUND TO ASN B 139
13	BC4	SOFTWARE	ASN A:158 , NAG A:283 , HOH A:2028 , SER B:149 , GLN B:155 , ILE B:156 , ASN B:158 , PRO B:238 , HOH B:2040 , HOH B:2041	BINDING SITE FOR MONO-SACCHARIDE NAG B 283 BOUND TO ASN B 158
14	BC5	SOFTWARE	NAG A:284 , HOH A:2049 , ASN B:178 , ALA B:223 , VAL B:224 , VAL B:232 , GLU B:233 , CYS B:234 , GLY B:239 , PHE B:241 , HOH B:2040 , HOH B:2060	BINDING SITE FOR MONO-SACCHARIDE NAG B 284 BOUND TO ASN B 178
15	BC6	SOFTWARE	ASN B:182	BINDING SITE FOR MONO-SACCHARIDE NAG B 281 BOUND TO ASN B 182
16	BC7	SOFTWARE	TYR B:193 , TRP B:243 , ASN B:244	BINDING SITE FOR MONO-SACCHARIDE NAG B 287 BOUND TO ASN B 244
17	BC8	SOFTWARE	TYR A:48 , GLU A:80 , ASN A:82 , ARG A:84 , GLN A:85 , GLU A:88 , GLU A:92 , TYR A:94 , ARG A:97 , ASN A:105 , ASP A:106 , GLU A:107 , CA A:306	BINDING SITE FOR POLY-SACCHARIDE RESIDUES SIA A 301 THROUGH FUC A 304
18	BC9	SOFTWARE	TYR A:48 , GLU A:80 , ASN A:82 , ARG A:84 , GLN A:85 , GLU A:88 , GLU A:92 , TYR A:94 , ARG A:97 , ASN A:105 , ASP A:106 , GLU A:107 , CA A:306 , TYR B:48 , GLU B:80 , ASN B:82 , ARG B:84 , GLN B:85 , GLU B:88 , GLU B:92 , TYR B:94 , ARG B:97 , GLU B:98 , ASN B:105 , ASP B:106 , GLU B:107 , CA B:306	BINDING SITE FOR POLY-SACCHARIDE RESIDUES SIA B 301 THROUGH FUC B 304

Asymmetric Unit

No.	Residues
1	A:19	-	A:117
2	A:90	-	A:109
3	A:122	-	A:133
4	A:127	-	A:142
5	A:144	-	A:153
6	A:159	-	A:203
7	A:172	-	A:185
8	A:189	-	A:216
9	A:221	-	A:265
10	A:234	-	A:247
11	A:251	-	A:278
12	B:19	-	B:117
13	B:90	-	B:109
14	B:122	-	B:133
15	B:127	-	B:142
16	B:144	-	B:153
17	B:159	-	B:203
18	B:172	-	B:185
19	B:189	-	B:216
20	B:221	-	B:265
21	B:234	-	B:247
22	B:251	-	B:278

Asymmetric Unit

No.	Residues
1	Glu A:80	-	Pro A:81
2	Glu B:80	-	Pro B:81

Asymmetric Unit (5, 10)

								dbSNP	PDB
No.	Source	Variant ID	Variant			UniProt ID	Status	ID	Chain	Variant
1	UniProt	VAR_014301	M	31	I	LYAM2_HUMAN	Polymorphism	3917408	A/B	M	10	I
2	UniProt	VAR_011790	C	130	W	LYAM2_HUMAN	Polymorphism	5360	A/B	C	109	W
3	UniProt	VAR_004191	S	149	R	LYAM2_HUMAN	Polymorphism	5361	A/B	S	128	R
4	UniProt	VAR_014302	Q	257	P	LYAM2_HUMAN	Polymorphism	3917422	A/B	Q	236	P
5	UniProt	VAR_011791	E	295	K	LYAM2_HUMAN	Polymorphism	5364	A/B	E	274	K

SNP/SAP Summary Statistics (UniProtKB/Swiss-Prot)

Biological Unit 1 (5, 5)

								dbSNP	PDB
No.	Source	Variant ID	Variant			UniProt ID	Status	ID	Chain	Variant
1	UniProt	VAR_014301	M	31	I	LYAM2_HUMAN	Polymorphism	3917408	A	M	10	I
2	UniProt	VAR_011790	C	130	W	LYAM2_HUMAN	Polymorphism	5360	A	C	109	W
3	UniProt	VAR_004191	S	149	R	LYAM2_HUMAN	Polymorphism	5361	A	S	128	R
4	UniProt	VAR_014302	Q	257	P	LYAM2_HUMAN	Polymorphism	3917422	A	Q	236	P
5	UniProt	VAR_011791	E	295	K	LYAM2_HUMAN	Polymorphism	5364	A	E	274	K

SNP/SAP Summary Statistics (UniProtKB/Swiss-Prot)

Biological Unit 2 (5, 5)

								dbSNP	PDB
No.	Source	Variant ID	Variant			UniProt ID	Status	ID	Chain	Variant
1	UniProt	VAR_014301	M	31	I	LYAM2_HUMAN	Polymorphism	3917408	B	M	10	I
2	UniProt	VAR_011790	C	130	W	LYAM2_HUMAN	Polymorphism	5360	B	C	109	W
3	UniProt	VAR_004191	S	149	R	LYAM2_HUMAN	Polymorphism	5361	B	S	128	R
4	UniProt	VAR_014302	Q	257	P	LYAM2_HUMAN	Polymorphism	3917422	B	Q	236	P
5	UniProt	VAR_011791	E	295	K	LYAM2_HUMAN	Polymorphism	5364	B	E	274	K

SNP/SAP Summary Statistics (UniProtKB/Swiss-Prot)

Asymmetric Unit (5, 10)

	PROSITE			UniProtKB		PDB
No.	ID	AC	Description	ID	Location	Count	Location
1	C_TYPE_LECTIN_1	PS00615	C-type lectin domain signature.	LYAM2_HUMAN	111-138	2	A:90-117 B:90-117
2	EGF_3	PS50026	EGF-like domain profile.	LYAM2_HUMAN	139-175	2	A:118-154 B:118-154
3	EGF_1	PS00022	EGF-like domain signature 1.	LYAM2_HUMAN	163-174	2	A:142-153 B:142-153
4	EGF_2	PS01186	EGF-like domain signature 2.	LYAM2_HUMAN	163-174	2	A:142-153 B:142-153
5	SUSHI	PS50923	Sushi/CCP/SCR domain profile.	LYAM2_HUMAN	178-239 240-301 315-364 378-427 441-490 491-549	4	A:157-218 B:157-218 A:219-280 B:219-280 - - - -

Biological Unit 1 (5, 6)

	PROSITE			UniProtKB		PDB
No.	ID	AC	Description	ID	Location	Count	Location
1	C_TYPE_LECTIN_1	PS00615	C-type lectin domain signature.	LYAM2_HUMAN	111-138	1	A:90-117 -
2	EGF_3	PS50026	EGF-like domain profile.	LYAM2_HUMAN	139-175	1	A:118-154 -
3	EGF_1	PS00022	EGF-like domain signature 1.	LYAM2_HUMAN	163-174	1	A:142-153 -
4	EGF_2	PS01186	EGF-like domain signature 2.	LYAM2_HUMAN	163-174	1	A:142-153 -
5	SUSHI	PS50923	Sushi/CCP/SCR domain profile.	LYAM2_HUMAN	178-239 240-301 315-364 378-427 441-490 491-549	2	A:157-218 - A:219-280 - - - - -

Biological Unit 2 (5, 6)

	PROSITE			UniProtKB		PDB
No.	ID	AC	Description	ID	Location	Count	Location
1	C_TYPE_LECTIN_1	PS00615	C-type lectin domain signature.	LYAM2_HUMAN	111-138	1	- B:90-117
2	EGF_3	PS50026	EGF-like domain profile.	LYAM2_HUMAN	139-175	1	- B:118-154
3	EGF_1	PS00022	EGF-like domain signature 1.	LYAM2_HUMAN	163-174	1	- B:142-153
4	EGF_2	PS01186	EGF-like domain signature 2.	LYAM2_HUMAN	163-174	1	- B:142-153
5	SUSHI	PS50923	Sushi/CCP/SCR domain profile.	LYAM2_HUMAN	178-239 240-301 315-364 378-427 441-490 491-549	2	- B:157-218 - B:219-280 - - - -

Asymmetric Unit (5, 10)

	ENSEMBL					UniProtKB			PDB
No.	Transcript ID	Exon	Exon ID	Genome Location	Length	ID	Location	Length	Count	Location	Length
1.1b	ENST00000333360	1b	ENSE00001950222	chr1:169703203-169703112	92	LYAM2_HUMAN	-	0	0	-	-
1.2a	ENST00000333360	2a	ENSE00001367867	chr1:169702801-169702717	85	LYAM2_HUMAN	1-13	13	0	-	-
1.3a	ENST00000333360	3a	ENSE00000814463	chr1:169702139-169701756	384	LYAM2_HUMAN	13-141	129	2	A:1-120 B:1-120	120 120
1.4a	ENST00000333360	4a	ENSE00000789645	chr1:169701083-169700976	108	LYAM2_HUMAN	141-177	37	2	A:120-156 B:120-156	37 37
1.5	ENST00000333360	5	ENSE00000789644	chr1:169699758-169699573	186	LYAM2_HUMAN	177-239	63	2	A:156-218 B:156-218	63 63
1.6	ENST00000333360	6	ENSE00000451012	chr1:169698814-169698629	186	LYAM2_HUMAN	239-301	63	2	A:218-280 B:218-280	63 63
1.7	ENST00000333360	7	ENSE00000789642	chr1:169698515-169698327	189	LYAM2_HUMAN	301-364	64	2	A:280-280 B:280-280	1 1
1.8	ENST00000333360	8	ENSE00000789641	chr1:169697387-169697199	189	LYAM2_HUMAN	364-427	64	0	-	-
1.9	ENST00000333360	9	ENSE00000451027	chr1:169697068-169696880	189	LYAM2_HUMAN	427-490	64	0	-	-
1.10	ENST00000333360	10	ENSE00000789639	chr1:169696666-169696490	177	LYAM2_HUMAN	490-549	60	0	-	-
1.11	ENST00000333360	11	ENSE00000451043	chr1:169695947-169695840	108	LYAM2_HUMAN	549-585	37	0	-	-
1.12	ENST00000333360	12	ENSE00000789637	chr1:169695069-169695048	22	LYAM2_HUMAN	585-592	8	0	-	-
1.13	ENST00000333360	13	ENSE00000814464	chr1:169694942-169694870	73	LYAM2_HUMAN	592-610	19	0	-	-
1.14a	ENST00000333360	14a	ENSE00000814465	chr1:169693650-169691782	1869	LYAM2_HUMAN	-	0	0	-	-

Asymmetric Unit

Reformat:	Number of residues per line = ('0' or empty: single-line sequence representation)
	Number of residues per labelling interval =
	UniProt sequence: complete aligned part

Show mapping:	SCOP domains	CATH domains	Pfam domains	Secondary structure (by author)
	SAPs(SNPs)	PROSITE motifs	Exons
	(details for a mapped element are shown in a popup box when the mouse pointer rests over it)

Chain A from PDB  Type:PROTEIN  Length:280
 aligned with LYAM2_HUMAN | P16581 from UniProtKB/Swiss-Prot  Length:610

    Alignment length:280
                                    31        41        51        61        71        81        91       101       111       121       131       141       151       161       171       181       191       201       211       221       231       241       251       261       271       281       291       301
          LYAM2_HUMAN    22 WSYNTSTEAMTYDEASAYCQQRYTHLVAIQNKEEIEYLNSILSYSPSYYWIGIRKVNNVWVWVGTQKPLTEEAKNWAPGEPNNRQKDEDCVEIYIKREKDVGMWNDERCSKKKLALCYTAACTNTSCSGHGECVETINNYTCKCDPGFSGLKCEQIVNCTALESPEHGSLVCSHPLGNFSYNSSCSISCDRGYLPSSMETMQCMSSGEWSAPIPACNVVECDAVTNPANGFVECFQNPGSFPWNTTCTFDCEEGFELMGAQSLQCTSSGNWDNEKPTCKA 301
               SCOP domains ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- SCOP domains
               CATH domains ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- CATH domains
               Pfam domains ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Pfam domains
         Sec.struct. author .eeee.....hhhhhhhhhhhh..ee....hhhhhhhhhhhh......eeeeeeee..eeee....ee.....................eeee..........eeee......eeeeee...........eeeee....eeeee...ee.....ee...........eeeeee..........eeeeee...eee.....ee.............eee...........eeee............eeeeee....eee...eee............eee. Sec.struct. author
                 SAPs(SNPs) ---------I--------------------------------------------------------------------------------------------------W------------------R-----------------------------------------------------------------------------------------------------------P-------------------------------------K------ SAPs(SNPs)
                PROSITE (1) -----------------------------------------------------------------------------------------C_TYPE_LECTIN_1             EGF_3  PDB: A:118-154                --SUSHI  PDB: A:157-218 UniProt: 178-239                        SUSHI  PDB: A:219-280 UniProt: 240-301                         PROSITE (1)
                PROSITE (2) ---------------------------------------------------------------------------------------------------------------------------------------------EGF_2       ------------------------------------------------------------------------------------------------------------------------------- PROSITE (2)
                PROSITE (3) ---------------------------------------------------------------------------------------------------------------------------------------------EGF_1       ------------------------------------------------------------------------------------------------------------------------------- PROSITE (3)
           Transcript 1 (1) Exon 1.3a  PDB: A:1-120 UniProt: 13-141 [INCOMPLETE]                                                                    -----------------------------------Exon 1.5  PDB: A:156-218 UniProt: 177-239                      -------------------------------------------------------------1 Transcript 1 (1)
           Transcript 1 (2) -----------------------------------------------------------------------------------------------------------------------Exon 1.4a  PDB: A:120-156            -------------------------------------------------------------Exon 1.6  PDB: A:218-280 UniProt: 239-301                       Transcript 1 (2)
                 4csy A   1 WSYNTSTEAMTYDEASAYCQQRYTHLVAIQNKEEIEYLNSILSYSPSYYWIGIRKVNNVWVWVGTQKPLTEEAKNWAPGEPNNRQKDEDCVEIYIKREKDVGMWNDERCSKKKLALCYTAACTNTSCSGHGECVETINNYTCKCDPGFSGLKCEQIVNCTALESPEHGSLVCSHPLGNFSYNSSCSISCDRGYLPSSMETMQCMSSGEWSAPIPACNVVECDAVTNPANGFVECFQNPGSFPWNTTCTFDCEEGFELMGAQSLQCTSSGNWDNEKPTCKA 280
                                    10        20        30        40        50        60        70        80        90       100       110       120       130       140       150       160       170       180       190       200       210       220       230       240       250       260       270       280

Chain B from PDB  Type:PROTEIN  Length:280
 aligned with LYAM2_HUMAN | P16581 from UniProtKB/Swiss-Prot  Length:610

    Alignment length:280
                                    31        41        51        61        71        81        91       101       111       121       131       141       151       161       171       181       191       201       211       221       231       241       251       261       271       281       291       301
          LYAM2_HUMAN    22 WSYNTSTEAMTYDEASAYCQQRYTHLVAIQNKEEIEYLNSILSYSPSYYWIGIRKVNNVWVWVGTQKPLTEEAKNWAPGEPNNRQKDEDCVEIYIKREKDVGMWNDERCSKKKLALCYTAACTNTSCSGHGECVETINNYTCKCDPGFSGLKCEQIVNCTALESPEHGSLVCSHPLGNFSYNSSCSISCDRGYLPSSMETMQCMSSGEWSAPIPACNVVECDAVTNPANGFVECFQNPGSFPWNTTCTFDCEEGFELMGAQSLQCTSSGNWDNEKPTCKA 301
               SCOP domains ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- SCOP domains
               CATH domains ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- CATH domains
               Pfam domains ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Pfam domains
         Sec.struct. author .eeee.....hhhhhhhhhhhh..ee....hhhhhhhhhhhh......eeeeeeee..eeee....ee.....................eeee..........eeee......eeeeee...........eeeee....eeeee...ee.....ee...........eeeeee..........eeeeee...eee.....ee.............eee...........eeee............eeeeee.....ee...eee............ee.. Sec.struct. author
                 SAPs(SNPs) ---------I--------------------------------------------------------------------------------------------------W------------------R-----------------------------------------------------------------------------------------------------------P-------------------------------------K------ SAPs(SNPs)
                PROSITE (1) -----------------------------------------------------------------------------------------C_TYPE_LECTIN_1             EGF_3  PDB: B:118-154                --SUSHI  PDB: B:157-218 UniProt: 178-239                        SUSHI  PDB: B:219-280 UniProt: 240-301                         PROSITE (1)
                PROSITE (2) ---------------------------------------------------------------------------------------------------------------------------------------------EGF_2       ------------------------------------------------------------------------------------------------------------------------------- PROSITE (2)
                PROSITE (3) ---------------------------------------------------------------------------------------------------------------------------------------------EGF_1       ------------------------------------------------------------------------------------------------------------------------------- PROSITE (3)
           Transcript 1 (1) Exon 1.3a  PDB: B:1-120 UniProt: 13-141 [INCOMPLETE]                                                                    -----------------------------------Exon 1.5  PDB: B:156-218 UniProt: 177-239                      -------------------------------------------------------------1 Transcript 1 (1)
           Transcript 1 (2) -----------------------------------------------------------------------------------------------------------------------Exon 1.4a  PDB: B:120-156            -------------------------------------------------------------Exon 1.6  PDB: B:218-280 UniProt: 239-301                       Transcript 1 (2)
                 4csy B   1 WSYNTSTEAMTYDEASAYCQQRYTHLVAIQNKEEIEYLNSILSYSPSYYWIGIRKVNNVWVWVGTQKPLTEEAKNWAPGEPNNRQKDEDCVEIYIKREKDVGMWNDERCSKKKLALCYTAACTNTSCSGHGECVETINNYTCKCDPGFSGLKCEQIVNCTALESPEHGSLVCSHPLGNFSYNSSCSISCDRGYLPSSMETMQCMSSGEWSAPIPACNVVECDAVTNPANGFVECFQNPGSFPWNTTCTFDCEEGFELMGAQSLQCTSSGNWDNEKPTCKA 280
                                    10        20        30        40        50        60        70        80        90       100       110       120       130       140       150       160       170       180       190       200       210       220       230       240       250       260       270       280

Legend:		→ Mismatch	(orange background)
	-	→ Gap	(green background, '-', border residues have a numbering label)
		→ Modified Residue	(blue background, lower-case, 'x' indicates undefined single-letter code, labelled with number + name)
	x	→ Chemical Group	(purple background, 'x', labelled with number + name, e.g. ACE or NH2)
	extra numbering lines below/above indicate numbering irregularities and modified residue names etc., number ends below/above '\|'

(no "SCOP Domain" information available for 4CSY)

(no "CATH Domain" information available for 4CSY)

(no "Pfam Domain" information available for 4CSY)

Asymmetric Unit(hide GO term definitions)

Chain A,B (LYAM2_HUMAN | P16581)

molecular function
	GO:0030246	carbohydrate binding	Interacting selectively and non-covalently with any carbohydrate, which includes monosaccharides, oligosaccharides and polysaccharides as well as substances derived from monosaccharides by reduction of the carbonyl group (alditols), by oxidation of one or more hydroxy groups to afford the corresponding aldehydes, ketones, or carboxylic acids, or by replacement of one or more hydroxy group(s) by a hydrogen atom. Cyclitols are generally not regarded as carbohydrates.
	GO:0070492	oligosaccharide binding	Interacting selectively and non-covalently with any oligosaccharide, a molecule with between two and (about) 20 monosaccharide residues connected by glycosidic linkages.
	GO:0043274	phospholipase binding	Interacting selectively and non-covalently with any phospholipase, enzymes that catalyze of the hydrolysis of a glycerophospholipid.
	GO:0005515	protein binding	Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).
	GO:0033691	sialic acid binding	Interacting selectively and non-covalently with sialic acid, any of a variety of N- or O- substituted derivatives of neuraminic acid, a nine carbon monosaccharide. Sialic acids often occur in polysaccharides, glycoproteins, and glycolipids in animals and bacteria.
	GO:0004888	transmembrane signaling receptor activity	Combining with an extracellular or intracellular signal and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity or state as part of signal transduction.
biological process
	GO:0030029	actin filament-based process	Any cellular process that depends upon or alters the actin cytoskeleton, that part of the cytoskeleton comprising actin filaments and their associated proteins.
	GO:0007202	activation of phospholipase C activity	The initiation of the activity of the inactive enzyme phospolipase C as the result of a series of molecular signals generated as a consequence of a G-protein coupled receptor binding to its physiological ligand.
	GO:0019722	calcium-mediated signaling	Any intracellular signal transduction in which the signal is passed on within the cell via calcium ions.
	GO:0007155	cell adhesion	The attachment of a cell, either to another cell or to an underlying substrate such as the extracellular matrix, via cell adhesion molecules.
	GO:0007157	heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules	The attachment of an adhesion molecule in one cell to a nonidentical adhesion molecule in an adjacent cell.
	GO:0006954	inflammatory response	The immediate defensive reaction (by vertebrate tissue) to infection or injury caused by chemical or physical agents. The process is characterized by local vasodilation, extravasation of plasma into intercellular spaces and accumulation of white blood cells and macrophages.
	GO:0007159	leukocyte cell-cell adhesion	The attachment of a leukocyte to another cell via adhesion molecules.
	GO:0050900	leukocyte migration	The movement of a leukocyte within or between different tissues and organs of the body.
	GO:0002523	leukocyte migration involved in inflammatory response	The movement of a leukocyte within or between different tissues and organs of the body contributing to an inflammatory response.
	GO:0050901	leukocyte tethering or rolling	Transient adhesive interactions between leukocytes and endothelial cells lining blood vessels. Carbohydrates on circulating leukocytes bind selectins on the vessel wall causing the leukocytes to slow down and roll along the inner surface of the vessel wall. During this rolling motion, transitory bonds are formed and broken between selectins and their ligands. Typically the first step in cellular extravasation (the movement of leukocytes out of the circulatory system, towards the site of tissue damage or infection).
	GO:0002092	positive regulation of receptor internalization	Any process that activates or increases the frequency, rate or extent of receptor internalization.
	GO:0050727	regulation of inflammatory response	Any process that modulates the frequency, rate or extent of the inflammatory response, the immediate defensive reaction (by vertebrate tissue) to infection or injury caused by chemical or physical agents.
	GO:0070555	response to interleukin-1	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an interleukin-1 stimulus.
	GO:0032496	response to lipopolysaccharide	Any process that results in a change in state or activity of an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a lipopolysaccharide stimulus; lipopolysaccharide is a major component of the cell wall of gram-negative bacteria.
	GO:0034612	response to tumor necrosis factor	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a tumor necrosis factor stimulus.
cellular component
	GO:0005901	caveola	A membrane raft that forms small pit, depression, or invagination that communicates with the outside of a cell and extends inward, indenting the cytoplasm and the cell membrane. Examples include flask-shaped invaginations of the plasma membrane in adipocytes associated with caveolin proteins, and minute pits or incuppings of the cell membrane formed during pinocytosis. Caveolae may be pinched off to form free vesicles within the cytoplasm.
	GO:0005905	clathrin-coated pit	A part of the endomembrane system in the form of an invagination of a membrane upon which a clathrin coat forms, and that can be converted by vesicle budding into a clathrin-coated vesicle. Coated pits form on the plasma membrane, where they are involved in receptor-mediated selective transport of many proteins and other macromolecules across the cell membrane, in the trans-Golgi network, and on some endosomes.
	GO:0030863	cortical cytoskeleton	The portion of the cytoskeleton that lies just beneath the plasma membrane.
	GO:0005615	extracellular space	That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid.
	GO:0016021	integral component of membrane	The component of a membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
	GO:0016020	membrane	A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it.
	GO:0045121	membrane raft	Any of the small (10-200 nm), heterogeneous, highly dynamic, sterol- and sphingolipid-enriched membrane domains that compartmentalize cellular processes. Small rafts can sometimes be stabilized to form larger platforms through protein-protein and protein-lipid interactions.
	GO:0048471	perinuclear region of cytoplasm	Cytoplasm situated near, or occurring around, the nucleus.
	GO:0005886	plasma membrane	The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.

Asymmetric Unit
	Complete Structure
		Jena3D(integrated viewing of ligand, site, SAP, PROSITE, SCOP information)
		WebMol \| AstexViewer[tm]@PDBe (Java Applets, require no local installation except for Java; loading may be slow)
		STRAP (Java WebStart application, automatic local installation, requires Java; full application with system access!)
		RasMol (require local installation)
		Molscript (VRML) (requires installation of a VRML viewer; select preferred view via VRML and generate a mono or stereo PDF format file)

	Ligands, Modified Residues, Ions
		CA	[ RasMol \| Jena3D ]	+environment [ RasMol \| Jena3D ]
		FUC	[ RasMol \| Jena3D ]	+environment [ RasMol \| Jena3D ]
		GAL	[ RasMol \| Jena3D ]	+environment [ RasMol \| Jena3D ]
		MAG	[ RasMol \| Jena3D ]	+environment [ RasMol \| Jena3D ]
		NAG	[ RasMol \| Jena3D ]	+environment [ RasMol \| Jena3D ]
		SIA	[ RasMol \| Jena3D ]	+environment [ RasMol \| Jena3D ]

	Sites
		AC1	[ RasMol ]	+environment [ RasMol ]
		AC2	[ RasMol ]	+environment [ RasMol ]
		AC3	[ RasMol ]	+environment [ RasMol ]
		AC4	[ RasMol ]	+environment [ RasMol ]
		AC5	[ RasMol ]	+environment [ RasMol ]
		AC6	[ RasMol ]	+environment [ RasMol ]
		AC7	[ RasMol ]	+environment [ RasMol ]
		AC8	[ RasMol ]	+environment [ RasMol ]
		AC9	[ RasMol ]	+environment [ RasMol ]
		BC1	[ RasMol ]	+environment [ RasMol ]
		BC2	[ RasMol ]	+environment [ RasMol ]
		BC3	[ RasMol ]	+environment [ RasMol ]
		BC4	[ RasMol ]	+environment [ RasMol ]
		BC5	[ RasMol ]	+environment [ RasMol ]
		BC6	[ RasMol ]	+environment [ RasMol ]
		BC7	[ RasMol ]	+environment [ RasMol ]
		BC8	[ RasMol ]	+environment [ RasMol ]
		BC9	[ RasMol ]	+environment [ RasMol ]

	Cis Peptide Bonds
		Glu A:80 - Pro A:81	[ RasMol ]
		Glu B:80 - Pro B:81	[ RasMol ]

Biological Units
	Complete Structure
		Biological Unit 1	[ Jena3D ]
		Biological Unit 2	[ Jena3D ]

Jmol
	protein: cartoon or spacefill or dots and stick; nucleic acid: cartoon and stick; ligands: spacefill; active site: stick [ Asym. Unit PNG format \| Asym. Unit - sites PNG format \| Biol. Unit 1 PNG format \| Biol. Unit 1 - sites PNG format \| Biol. Unit 2 PNG format ](automatic orientation, automatically generated)
Molscript
	protein, nucleic acid: cartoon; ligands: spacefill; active site: ball and stick [ mono PDF format \| stereo PDF format ](default orientation, automatically generated)

Access by PDB/NDB ID
	4csy
		Family and Domain Information	:	ProDom \| SYSTERS
		General Structural Information	:	GlycoscienceDB \| MMDB \| NDB \| OCA \| PDB \| PDBe \| PDBj \| PDBsum \| PDBWiki \| PQS \| PROTEOPEDIA
		Orientation in Membranes	:	OPM
		Protein Surface	:	SURFACE
		Secondary Structure	:	DSSP (structure derived) \| HSSP (homology derived)
		Structural Genomics	:	GeneCensus
		Structural Neighbours	:	CE \| VAST
		Structure Classification	:	CATH \| Dali \| SCOP
		Validation and Original Data	:	BMRB Data View \| BMRB Restraints Grid \| EDS \| PROCHECK \| RECOORD \| WHAT_CHECK

Access by UniProt ID/Accession number
	LYAM2_HUMAN \| P16581
		Comparative Protein Structure Models	:	ModBase
		Genomic Information	:	Ensembl
		Protein-protein Interaction	:	DIP
		Sequence, Family and Domain Information	:	InterPro \| Pfam \| SMART \| UniProtKB/SwissProt

Access by Enzyme Classificator (EC Number)
	(no 'Enzyme Classificator' available)
		General Enzyme Information	:	BRENDA \| EC-PDB \| Enzyme \| IntEnz
		Pathway	:	KEGG \| MetaCyc

Access by Disease Identifier (MIM ID)
	(no 'MIM ID' available)
		Disease Information	:	OMIM

Access by GenAge ID
	(no 'GenAge ID' available)
		Age Related Information	:	GenAge

Access by PDB/NDB ID
		Domain Information	:	XDom
		Interatomic Contacts of Structural Units	:	CSU
		Ligand-protein Contacts	:	LPC
		Protein Cavities	:	castP
		Sequence and Secondary Structure	:	PDBCartoon
		Structure Alignment	:	STRAP(Java WebStart application, automatic local installation, requires Java; full application with system access!)
		Structure and Sequence Browser	:	STING

Access by UniProt ID/Accession number
	LYAM2_HUMAN \| P16581
		Protein Disorder Prediction	:	DisEMBL \| FoldIndex \| GLOBPLOT (for more information see DisProt)

UniProtKB/Swiss-Prot
	LYAM2_HUMAN \| P16581	:	1esl 1g1t 1kja 4c16

4css	CRYSTAL STRUCTURE OF FIMH IN COMPLEX WITH A SULFONAMIDE BIPHENYL ALPHA D-MANNOSIDE
4cst	CRYSTAL STRUCTURE OF FIMH IN COMPLEX WITH 3'-CHLORO- 4'-(ALPHA-D-MANNOPYRANOSYLOXY)-BIPHENYL-4-CARBONITRILE

Description

Compounds

Structural Features

Chains, Units

Ligands, Modified Residues, Ions (6, 24)

Sites (18, 18)

SS Bonds (22, 22)

Cis Peptide Bonds (2, 2)

Sequence-Structure Mapping

SAPs(SNPs)/Variants (5, 10)

PROSITE Motifs (5, 10)

Exons (5, 10)

Sequences/Alignments

Classification and Annotation

SCOP Domains (0, 0)

CATH Domains (0, 0)

Pfam Domains (0, 0)

Gene Ontology (30, 30)

Visualization

Interactive Views

Still Images

Databases and Analysis Tools

Databases

Analysis Tools

Related Entries

Entries Sharing at Least One Protein Chain (UniProt ID)

Related Entries Specified in the PDB File